Home›Companies›Biotech & Pharma›Autobahn Therapeutics

Autobahn Therapeutics, Inc.

Updated Oct 29, 2026·Latest SEC filing Aug 1, 2024·Suggest an edit

About Autobahn Therapeutics

Autobahn Therapeutics is a private company based in San Diego, California. It has reported $100,825,289 raised in one offering on Form D since August 2024.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 20, 2024Aug 1, 2024$100,825,289of $120.0M target22$4.5MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Autobahn Therapeutics's Form D filed Aug 1, 2024.

US
JB
KB
TC
PD
KF
Kevin Finney
Executive officer and director

Sources

  1. SECAutobahn Therapeutics, Inc. filing history